Deep Genomics

Biotechnology Research

Deep Genomics is using artificial intelligence to build a new universe of life-saving genetic therapies. The future of medicine will rely on artificial intelligence, because biology is too complex for humans to understand. At Deep Genomics, our geneticists, molecular biologists and chemists develop new ways of detecting and treating disease using our biologically accurate artificial intelligence technology.

Adam  D'Augelli

Adam D'Augelli

  • Board Member
Maryanna Saenko

Maryanna Saenko

  • Board Member
Nessan Bermingham

Nessan Bermingham

  • Board Member
Jacqueline Fok

Jacqueline Fok

  • Board Member
Dion Madsen

Dion Madsen

  • Board Observer
William  D

William D

  • Chair
Brian  O'Callaghan

Brian O'Callaghan

  • Board Member
David  Johnston

David Johnston

  • Chief Financial Officer
Brendan  Frey

Brendan Frey

  • Board Member
Tom  Masterson

Tom Masterson

  • Chief Operating Officer
Clive  Bertram

Clive Bertram

  • Chief Business Officer
Matt  Cahill J.D

Matt Cahill J.D

  • Chief Strategy Officer
Jing  Ge

Jing Ge

  • Vice President of Strategy and Business Development
Radu  Dobri

Radu Dobri

  • Chief Technology Officer
Greg  Hoffman

Greg Hoffman

  • Chief Scientific Officer
Tehmina  Masud

Tehmina Masud

  • Vice President and Head of Target Identification
Joel  Shor

Joel Shor

  • Vice President and Head of Machine Learning
Muse

Muse

  • Unlocking the brain, revolutionizing health
Biofect Innovations

Biofect Innovations

  • Creating sustainable ingredients for a healthier planet
Spiderwort

Spiderwort

  • Developing revolutionary biomaterials for regenerative medicine.